Until now, only α-synuclein, a classical CSF Alzheimer’s disease biomarker, and neurofilament light (NFL) chains have turned out to be helpful in differential diagnosis between PD and healthy control subjects. This evidence concerns the gene SNCA and early-onset autosomal dominant Alzheimer disease.